pharmaceuticals

After starting the year on a high note, the IPO market is currently going through a slow phase mainly due…

Meihua International Medical Technologies is the latest healthcare company to seek Wall Street listing, even as the IPO market picks…

Aurora Cannabis, Inc. (NYSE: ACB) on Thursday reported a narrower net loss for the second quarter of 2022. The company's…

Cannabis producer Canopy Growth Corporation (NASDAQ: CGC) reported a narrower net loss for the third quarter of 2022, despite an…

Pfizer Inc. (NYSE: PFE) reported fourth quarter 2021 earnings results today. Revenues doubled year-over-year to $23.8 billion. Excluding contributions from…

The biomedical industry grew at an accelerated pace in 2021 even as healthcare systems went into overdrive amidst the COVID-induced…

Bristol Myers Squibb (NYSE: BMY) reported fourth quarter 2021 earnings results today. Total revenues increased 8% year-over-year to $12 billion,…

Pharmaceuticals company Merck & Co., Inc. (NYSE: MRK) has reported stronger-than expected earnings and revenues for the fourth quarter. The…

Eli Lilly and Company (NYSE: LLY) reported revenue of $7.9 billion for the fourth quarter of 2021, up 8% year-over-year.…

The IPO market is recovering from the slowdown experienced towards the end of 2021, with pharma companies dominating the scene…

Johnson & Johnson (NYSE: JNJ) reported fourth-quarter 2021 financial results before the regular market hours on Tuesday. The pharmaceutical giant…

The pharma sector has been on a stable growth trajectory lately, and the trend gathered momentum when the pandemic-related emergency…

Tilray (NASDAQ: TLRY) reported second-quarter 2022 financial results before the regular market hours on Monday. Total net revenue increased 20%…

Walgreens Boots Alliance Inc.  (NASDAQ: WBA) Q1 2022 earnings call dated Jan. 06, 2022, Call participants: Tiffany Kanaga -- Vice…

There are quite a few pharmaceutical companies lined up to make their market debut this week. Among these is Amylyx…

Trxade Health Inc. (NASDAQ: MEDS) is a healthcare service technology platform that mainly serves the secondary pharmaceutical supply chain, offering…

As the first week of the new year slowly unfolds, it appears the pharmaceutical industry is taking the front seat…

The healthcare sector, led by pharmaceutical and biotechnology firms, has contributed significantly to the IPO boom that sent the market…

Caption: iStock Biofrontera Inc. (Nasdaq: BFRI) is a biopharmaceutical company providing specialty dermatology therapies and services in the United States.…

Eli Lilly and Company (NYSE: LLY) reported revenue of $6.7 billion for the third quarter of 2021, up 18% year-over-year.…

After months of hectic activity, the IPO market experienced a lull in the Thanksgiving week, but it is still headed…